Please login to the form below
New accounts: November
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com.
|
|
|
|
|
|
Bristol-Myers Squibb |
New product |
Ultrasound contrast agents |
PAN Advertising |
|
Cardinal Health |
Physeptone |
Addiction |
Lowe Azure |
|
Cardinal Health Martindale Products |
Pre-filled syringes |
Hospital speciality |
Pulsar Healthcare Communications |
|
Link Pharmaceuticals |
Gliadel implant |
Oncology |
Addjuice |
|
Mayne Pharma |
N/A |
Full portfolio |
Swordfish Advertising |
|
Napp Pharmaceuticals |
BuTrans |
Pain relief |
Langland |
|
Roche |
New product |
Oncology |
MJL |
|
Royal Free Hospital |
Fundraising |
HIV/HCV/HBV |
MJL |
|
Royal Numico (global) |
Cubitan |
Woundcare nutrition |
central |
|
Royal Numico (global) |
Cubison |
Woundcare nutrition |
central |
|
Wyeth |
Efexor XL |
Psychiatry |
PAN Advertising |
Share
Related Hub content
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Takeda’s dengue vaccine receives MHRA approval for those aged four years and older
- Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
- Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients
- NHS urges people yet to receive their COVID-19 booster to come forward
- Biosimilars and beyond: innovating for improved patient outcomes
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Why female mentorship is so powerful in pharma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Europe’s cancer community publishes new report on transforming patient care
- Digital technology: a significant change in healthcare innovation
- Assessing the value of interim analyses in clinical trials
PMHub
Apex.co.uk Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...
Latest intelligence
- Biosimilars and beyond: innovating for improved patient outcomes
- How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
